+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-06-05Number of Pages: 180

Genomics Personalized Health Market (Technology - NGS platforms, RT-PCR, Microarray, and Genetic Analyzers; Test Type - Oncology testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, and Obstetrics Testing; End User - Academics & Research Institutes and Diagnostic Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024

Global Genomics Personalized Health Market: Snapshot

The global market for genomics personalized health is set to create a remarkable incremental opportunity in the come years owing to rise in the biopharmaceutical and healthcare industry. The other drivers for global genomics personalized health the market are increase in prevalence of cancer, increase in geriatric population, increasing attentiveness towards health in emerging economies. Transparency Market Research estimates that the global genomics personalized health market will expand at a CAGR of 14.9% over the forecast period between 2017 and 2025. The global market is estimated to reach US$25,112.5 mn by the end of 2025 from US$7,243.0 mn in 2016. 

Based on technology type the market is segmented as NGS platforms, RT-PCR, microarray, genetic analyzers, and others. In 2016, the NGS platform segment under technology type held a prominent market share of over 32.0% of the global genomics personalized health market. This segment is expected to propel with high growth rate during the forecast period as compared to other segments. Its growth will be associated with introduction of highly efficient technologies and instruments by leading companies such as F. Hoffmann- La Roche, Thermo Fisher Scientific and Illumina Inc. This segment consists of the most prominent best-selling and advance sequencing products used for various genetic analysis. 

genomics personalized health market

Diagnostic Centers and Academic and Research Institutes Lead the Pack due to Growing Investments in R&D

On the basis of end users, the global genomics personalized health market is divided into academics and research institutes, diagnostic centers, and others. Diagnostic centers and academic and research institutes are the major shareholders in the genomics personalized health market with a combined share of around 88.0%, as was recorded in 2016. In April, 2017, the Institute of Medical Genetics and Pathology and Thermo Fisher Scientific at University Hospital Basel signed a strategic agreement for development and validation of next-generation sequencing (NGS)-based cancer diagnostics. Thus, the increasing research activities in the field of genomics along with increase in genetic disorders, increasing strategic alliance between market leaders, and research institutes is expected to drive these segments over the forecast period. 

Asia Pacific to Offer Lucrative Opportunities due to Increasing Awareness about Diseases

The global genomics personalized health market has been segregated into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa in terms of geography. The North America genomics personalized health market accounts for major share of the global market in 2016, followed by Europe.  Asia Pacific is expected to grow at a faster rate due to advanced acceptance rate for innovative technology in the region. Latin America is anticipated to provide lucrative opportunities to the global manufacturers in the region due to increasing awareness and increase in healthcare expenditure, the industry will enhance the demand for genomics personalized health system in this region. Others reason for the market growth are expanding pharmaceutical and biotechnology companies in Mexico and Brazil has provided lucrative growth prospects for the genomics personalized health market in the region. The MEA genomics personalized health market is expected to grow at a lower rate when compared to other regions in global genomics personalized health market. 

Leading players in the genomics personalized health market include are QIAGEN, Illumina, Inc. Thermo Fisher Scientific, Inc. Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Lonza Group, INVITAE Corporation, Genetic Technologies Limited, Interleukin Genetics Inc., Eastern Biotech and Life Sciences, DNA Genotek Inc. (Subsidiary of OraSure Technologies, Inc.), uBiome, Inc., and XCode Life Sciences Private Limited.

Global Genomics Personalized Health Market: Overview

This report on Genomics Personalized Health market studies the current as well as future forecasts of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacturing and commercialization of various Genomics Personalized Health instrument and products as well as new entrants planning to enter this market. This report covers an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered within the scope of the study. This section also provides the overall information and data analysis of the global Genomics Personalized Health market with respect to the prominent market segments based on major technology, test type, end-user, and geographies. 

Global Genomics Personalized Health Market: Segmentation

The global Genomics Personalized Health market is divided into: by technology, by test type, by end-user and by geography. On the basis of technology the Genomics Personalized Health market is segmented as NGS platforms, RT-PCR, Microarray, Genetic analyzers, and. On the basis of test type Genomics Personal Health Market is segmented as oncology testing, infectious disease testing, orphan disease testing, autoimmune disease testing, obstetrics testing, and others. On the basis of end-user the Genomics Personalized Health market is classified as academics & research Institutes, diagnostic centers, and others. The market for the above mentioned segments of global personalized health market has been comprehensively analyzed based on their utility, effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn along with the compound annual growth rate (CAGR %) from 2017 to 2025 has been provided for all segments, considering 2016 as the base year. 

Global Genomics Personalized Health Market: Drivers and Trends

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the global Genomics Personalized Health market and can influence the market in the near future. Market attractiveness analysis has been provided in all the sections of the report in order to explain the intensity of competition in the global genomics personalized health market across different types of technologies/test type/end-users/geographies. The competitive scenario among different market players in global genomics personalized health market is evaluated through market share analysis in the competition landscape section of the report. The section also comprises of completion matrix that analyzes the competition among some of the top global players operating in the genomics personalized health market. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market. 

Global Genomics Personalized Health Market: Regional Outlook

Geographically, the Genomics Personalized Health market has been segmented into five regions: North America, Europe, Asia Pacific, Europe, Middle East & Africa (MEA), and Latin America. Each regional market for Genomics Personalized Health market has been further categorized into major technology, test type and end-user segments considered within the scope of the study. Key country (U.S., Canada, Japan, Germany, France, U.K., Australia, Canada, China, Brazil, Mexico, India, etc.) market revenues have also been provided in different regional sections within the report. Market revenue in terms of US$ Mn for the period from 2015 to 2025 along with CAGR % from 2017 to 2025 are provided for all the regions and nations considering 2016 as the base year. 

Key Players Mentioned in this Report are:

The report profiles key manufacturers in the Genomics Personalized Health market based on various characteristics such as company details, SWOT analysis, strategic overview, financials, and business overview. Major players profiled in this report include QIAGEN, Illumina, Inc., Thermo Fisher Scientific, Inc. Bio-Rad Laboratories, Inc. ,F. Hoffmann-La Roche AG, Lonza Group, INVITAE Corporation, Genetic Technologies Limited, Interleukin Genetics Inc., Eastern Biotech and Life Sciences, DNA Genotek Inc. (Subsidiary of OraSure Technologies, Inc.),uBiome, Inc., and XCode Life Sciences Private Limited. 

The global Genomics Personalized Health market has been segmented as follows:

Genomics Personalized Health Market, by Technology

  • NGS platforms
  • RT-PCR
  • Microarray
  • Sequencing and genetic analyzers
  • Others 

Genomics Personalized Health Market, by Test Type

  • Oncology testing
  • Infectious disease testing
  • Orphan disease testing
  • Autoimmune disease testing
  • Obstetrics testing
  • Others 

Genomics Personalized Health Market, By End-User

  • Academics & Research Institutes
  • Diagnostic Centers
  • Others

Genomics Personalized Health Market, by Geography 

North America

  • U.S.
  • Canada

Europe

  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa


 
 
Back To Top